The Perfect Enemy | Category: Social Impact | Page 786
October 3, 2025

Social Impact

Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants

Novavax prototype vaccine (NVX-CoV2373) demonstrates broad immune responses including against Omicron and other circulating variantsPre-clinical data demonstrated that boosting with...